Key FInancial Inc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Key FInancial Inc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$474
-22.5%
150.0%0.00%
Q2 2023$612
+9.5%
150.0%0.00%
Q1 2023$559
-33.4%
150.0%0.00%
Q4 2022$839
-16.1%
150.0%0.00%
Q3 2022$1,0000.0%150.0%0.00%
-100.0%
Q2 2022$1,0000.0%150.0%0.00%
Q1 2022$1,000
-50.0%
150.0%0.00%
-100.0%
Q4 2021$2,0000.0%150.0%0.00%0.0%
Q3 2021$2,0000.0%150.0%0.00%0.0%
Q2 2021$2,000
+100.0%
150.0%0.00%0.0%
Q1 2021$1,000150.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 752,024$100,884,00018.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 420,859$56,458,0004.40%
Discovery Value Fund 922,411$123,741,0003.63%
MPM BioImpact LLC 162,620$21,815,0003.38%
Ally Bridge Group (NY) LLC 65,000$8,720,0002.56%
ARK Investment Management 6,743,556$904,648,0002.17%
Integral Health Asset Management, LLC 50,000$6,708,0001.93%
Yorktown Management & Research Co Inc 18,300$2,455,0001.85%
Interchange Capital Partners, LLC 8,191$1,098,0001.84%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$14,950,0001.76%
View complete list of INTELLIA THERAPEUTICS INC shareholders